TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the…
HALIFAX, Nova Scotia, Nov. 30, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported…
PITTSBURGH, Nov. 30, 2021 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), the…
PRINCETON, N.J., Nov. 30, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Unique PD-L1-mediated immune changes and early signs of anti-tumor activity with MT-6402 Continued dose-finding with…
MELBOURNE, Australia and PORTO ALEGRE, Brazil, Nov. 30, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited…
TUSTIN, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics…
New trial is in collaboration with Japan’s National Center for Geriatrics and Gerontology (NCGG) and…
COURT SANCTIONS THE SCHEME OF ARRANGEMENT LONDON, Nov. 30, 2021 (GLOBE NEWSWIRE) — Reference is…
Company announcement – No. 73 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies,…
EUROBIO SCIENTIFIC LAUNCHES THE FIRST PCR TEST ALLOWING SIMULTANEOUS SARS-COV-2 VIRUS SCREENING AND DETECTION OF…
Company announcement no. 23 – 2130 November 2021 NOT FOR DISTRIBUTION IN THE UNITED STATES,…
Company announcement – No. 72 / 2021 Total number of shares and voting rights in Zealand…
Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of…
Conference call at 4:30 p.m. Eastern time today WOBURN, Mass., Nov. 30, 2021 (GLOBE NEWSWIRE)…
Dr. Arron brings nearly two decades of scientific leadership in biotech drug discovery and development…
JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy (TRT) in…
Lund, Sweden — November 30, 2021 – Active Biotech and its partner NeoTX announced that…
TEMPE, Ariz., Nov. 30, 2021 (GLOBE NEWSWIRE) — OnePoint Patient Care (OnePoint) is continuing to…
Strategic hire will expand Company’s commercial presence in key geography MENLO PARK, Calif., Nov. 30,…